HPV-associated head and neck cancer: a virus-related cancer epidemic (scientific article)

cites work (P2860)

Q91634739	"Cold turkey" or pharmacotherapy: Examination of tobacco cessation methods tried among smokers prior to developing head and neck cancer
Q102373874	3D Oral and Cervical Tissue Models for Studying Papillomavirus Host-Pathogen Interactions
Q36174094	A Comprehensive Analysis on the Association between Tobacco-Free Betel Quid and Risk of Head and Neck Cancer in Taiwanese Men.
Q90287047	A Phase II Study of Tumor-infiltrating Lymphocyte Therapy for Human Papillomavirus-associated Epithelial Cancers
Q35025767	A Review of Carcinomas Arising in the Head and Neck Region in HIV-Positive Patients
Q58700166	A Review of HPV-Related Head and Neck Cancer
Q37694836	A critical review of cost-effectiveness analyses of vaccinating males against human papillomavirus
Q53463816	A dielectrophoretic method of discrimination between normal oral epithelium, and oral and oropharyngeal cancer in a clinical setting.
Q36000879	A different entity: a population based study of characteristics and recurrence patterns in oropharyngeal squamous cell carcinomas
Q39468831	A faith- and community-based approach to identifying the individual at risk for head and neck cancer in an inner city
Q37376305	A functional variant at miRNA-122 binding site in IL-1a 3' UTR predicts risk of recurrence in patients with oropharyngeal cancer
Q34388174	A humanized mouse model of HPV-associated pathology driven by E7 expression
Q35133375	A novel curcumin analog (H-4073) enhances the therapeutic efficacy of cisplatin treatment in head and neck cancer
Q36827520	A novel prediction model for human papillomavirus-associated oropharyngeal squamous cell carcinoma using p16 and subcellular β-catenin expression
Q36630457	A patient-centered approach to counseling patients with head and neck cancer undergoing human papillomavirus testing: a clinician's guide
Q35945485	A pilot study to compare the detection of HPV-16 biomarkers in salivary oral rinses with tumour p16(INK4a) expression in head and neck squamous cell carcinoma patients
Q92618183	A prognostic scoring model based on the HPV status of oropharyngeal carcinoma patients treated with postoperative radiotherapy in China
Q55474391	A rapidly growing human papillomavirus-positive oral tongue squamous cell carcinoma in a 21-year old female: A case report.
Q90101423	A review of the electronic two-week rule referrals for head and neck cancer to Western Sussex Hospitals NHS Foundation Trust
Q34756970	A sex-specific association between a 15q25 variant and upper aerodigestive tract cancers
Q34498577	A single centre experience with sequential and concomitant chemoradiotherapy in locally advanced stage IV tonsillar cancer
Q88517312	A snapshot of the evolving epidemiology of oropharynx cancers
Q64075320	A systematic review of the HPV-attributable fraction of oropharyngeal squamous cell carcinomas in Germany
Q48240243	AHNS Series: Do you know your guidelines? Principles of treatment for locally advanced or unresectable head and neck squamous cell carcinoma.
Q54377519	Absence of human papillomavirus in patients with breast cancer in north-west China.
Q34596781	Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer
Q64137504	Addressing the Declining Rates of Completion and Gender Coverage Inequity in Human Papillomavirus Vaccination in the United States
Q37407758	Adequacy of fine-needle aspiration specimens for human papillomavirus infection molecular testing in head and neck squamous cell carcinoma
Q28087186	Advanced drug delivery systems for local treatment of the oral cavity
Q35952618	Age Effects and Temporal Trends in HPV-Related and HPV-Unrelated Oral Cancer in the United States: A Multistage Carcinogenesis Modeling Analysis
Q99352682	Age and risk of recurrence in oral tongue squamous cell carcinoma: Systematic review
Q48285879	Age-specific incidence and treatment patterns of head and neck cancer in the Netherlands-A cohort study.
Q45328734	Agent Orange exposure and cancer incidence in Korean Vietnam veterans: a prospective cohort study.
Q35858231	Alcohol Drinking Obliterates the Inverse Association Between Serum Retinol and Risk of Head and Neck Cancer
Q89033954	An Automated Microfluidic Assay for Photonic Crystal Enhanced Detection and Analysis of an Antiviral Antibody Cancer Biomarker in Serum
Q38838178	An HPV-E6/E7 immunotherapy plus PD-1 checkpoint inhibition results in tumor regression and reduction in PD-L1 expression
Q38856442	An audit of the results of a triplet metronomic chemotherapy regimen incorporating a tyrosine kinase inhibitor in recurrent/metastatic head and neck cancers patients
Q45072956	An oral keratinocyte life cycle model identifies novel host genome regulation by human papillomavirus 16 relevant to HPV positive head and neck cancer
Q38100179	An update on the clinical pathology of oral precancer and cancer
Q33566622	Analysis of The Cancer Genome Atlas sequencing data reveals novel properties of the human papillomavirus 16 genome in head and neck squamous cell carcinoma
Q34051977	Analysis of exhaled breath for diagnosing head and neck squamous cell carcinoma: a feasibility study
Q36075038	Apoptotic variants as predictors of risk of oropharyngeal cancer recurrence after definitive radiotherapy
Q57167219	Application of a Health Literacy Framework to Explore Patients' Knowledge of the Link between HPV and Cancer
Q35403352	Application of the hybrid capture 2 assay to squamous cell carcinomas of the head and neck: a convenient liquid-phase approach for the reliable determination of human papillomavirus status.
Q35117498	Aspects of prophylactic vaccination against cervical cancer and other human papillomavirus-related cancers in developing countries
Q35589619	Assembly and initial characterization of a panel of 85 genomically validated cell lines from diverse head and neck tumor sites.
Q34677186	Assessment of human papillomavirus in lung tumor tissue
Q52906171	Association Between PD-L1 and HPV Status and the Prognostic Value of PD-L1 in Oropharyngeal Squamous Cell Carcinoma.
Q35681493	Association of the XPA A23G polymorphism with the risk of head and neck carcinomas: Evidence from 5,491 subjects
Q40264165	Attitudes toward Human Papilloma Virus Vaccination and Head and Neck Cancer Prevention in a Diverse, Urban Population
Q38109246	Autoimmunity vs. cancer: predator vs. alien?
Q36295602	Autophagy regulates UBC9 levels during viral-mediated tumorigenesis.
Q87451763	Barrett's Esophagus
Q36529848	Basics of tumor development and importance of human papilloma virus (HPV) for head and neck cancer
Q33924824	Behavioral Decision Research Intervention Reduces Risky Sexual Behavior
Q61796341	Brain-Derived Neurotrophin and TrkB in Head and Neck Squamous Cell Carcinoma
Q34572271	Burden of human papillomavirus infection and related comorbidities in men: implications for research, disease prevention and health promotion among Hispanic men
Q35930546	C3-Luc Cells Are an Excellent Model for Evaluation of Cellular Immunity following HPV16L1 Vaccination
Q42690795	Cancer incidence in Germany attributable to human papillomavirus in 2013.
Q43856455	Cancer-related risk factors and preventive measures in US Hispanics/Latinos
Q95273036	Cervical and oral human papillomavirus infection in women living with human immunodeficiency virus (HIV) and matched HIV-negative controls in Brazil
Q42249020	Cervista HPV assays for fine-needle aspiration specimens are a valid option for human papillomavirus testing in patients with oropharyngeal carcinoma
Q37866779	Cetuximab in the treatment of squamous cell carcinoma of the head and neck
Q36880604	Cetuximab: its unique place in head and neck cancer treatment
Q38807472	Challenges in establishing the diagnosis of human papillomavirus-related oropharyngeal carcinoma.
Q40184512	Challenges to effective cancer control in China, India, and Russia
Q40666818	Challenging 'girls only' publicly funded human papillomavirus vaccination programmes
Q41335240	Changing prognostic significance of tumor stage and nodal stage in patients with squamous cell carcinoma of the oropharynx in the human papillomavirus era.
Q35853734	Characteristics and kinetics of cervical lymph node regression after radiation therapy for human papillomavirus-associated oropharyngeal carcinoma: quantitative image analysis of post-radiotherapy response
Q33699267	Characteristics and predictors of oral cancer knowledge in a predominantly African American community
Q35870672	Characteristics and survival of head and neck cancer by HPV status: a cancer registry-based study
Q36523118	Characterization of human papillomavirus type 120: a novel betapapillomavirus with tropism for multiple anatomical niches.
Q35154318	Characterization of two novel gammapapillomaviruses, HPV179 and HPV184, isolated from common warts of a renal-transplant recipient
Q62837830	Childhood passive smoke exposure is associated with adult head and neck cancer
Q45126102	Chromosome stability in tonsillar squamous cell carcinoma is associated with HPV16 integration and indicates a favorable prognosis
Q33643550	Chronic periodontitis and its possible association with oral squamous cell carcinoma - a retrospective case control study.
Q58543451	Ciliated HPV-Related Carcinoma: A Diagnostic Challenge on Frozen Section
Q35803222	Ciliated HPV-related Carcinoma: A Well-differentiated Form of Head and Neck Carcinoma That Can Be Mistaken for a Benign Cyst
Q40681336	Classification of TP53 mutations and HPV predict survival in advanced larynx cancer
Q31127773	Clinical and molecular characteristics of HNSCC patients with brain metastases: a retrospective study
Q34031281	Clinical and scientific impact of human papillomavirus on head and neck cancer
Q92711834	Clinical characteristics and treatment outcome of oropharyngeal squamous cell carcinoma in an endemic betel quid region
Q43630823	Clinical characteristics of patients with multiple potentially human papillomavirus-related malignancies.
Q30249150	Clinical features and treatment strategy for HPV-related oropharyngeal cancer.
Q42174794	Clinical relevance of systematic human papillomavirus (HPV) diagnosis in oral squamous cell carcinoma
Q55247907	Clinico-pathological features of oropharyngeal squamous cell carcinomas in Malaysia with reference to HPV infection.
Q91651290	Combination of fenretinide and ABT-263 induces apoptosis through NOXA for head and neck squamous cell carcinoma treatment
Q90911050	Combined CT radiomics of primary tumor and metastatic lymph nodes improves prediction of loco-regional control in head and neck cancer
Q64112453	Combined Transcriptome and Proteome Analysis of Immortalized Human Keratinocytes Expressing Human Papillomavirus 16 (HPV16) Oncogenes Reveals Novel Key Factors and Networks in HPV-Induced Carcinogenesis
Q60363744	Combined human papillomavirus typing and TP53 mutation analysis in distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma
Q40473479	Common fragile sites (CFS) and extremely large CFS genes are targets for human papillomavirus integrations and chromosome rearrangements in oropharyngeal squamous cell carcinoma.
Q38745800	Comparison of human papillomavirus type 16 replication in tonsil and foreskin epithelia
Q36067876	Comparison of the miRNA profiles in HPV-positive and HPV-negative tonsillar tumors and a model system of human keratinocyte clones.
Q49816565	Computational methods reveal novel functionalities of PIWI-interacting RNAs in human papillomavirus-induced head and neck squamous cell carcinoma.
Q41188570	Computer Literacy and Health Locus of Control as Determinants for Readiness and Acceptability of Telepractice in a Head and Neck Cancer Population
Q28397537	Computer-aided targeting of the PI3K/Akt/mTOR pathway: toxicity reduction and therapeutic opportunities
Q38638947	Conceiving a national head and neck cancer screening programme
Q37385870	Concordant Oral-Genital HPV Infection in South Africa Couples: Evidence for Transmission
Q91641493	Concurrent cisplatin or cetuximab with radiotherapy for HPV-positive oropharyngeal cancer: Medical resource use, costs, and quality-adjusted survival from the De-ESCALaTE HPV trial
Q44444943	Consumption of vegetables and fruits and risk of subtypes of head-neck cancer in the Netherlands Cohort Study
Q37950290	Contemporary management of lymph node metastases from an unknown primary to the neck: II. a review of therapeutic options
Q26824273	Correlation between human papillomavirus and p16 overexpression in oropharyngeal tumours: a systematic review
Q35154161	Correlation of LMP10 expression and clinical outcome in Human Papillomavirus (HPV) positive and HPV-Negative tonsillar and base of tongue cancer
Q36061991	Correlation of PET-CT nodal SUVmax with p16 positivity in oropharyngeal squamous cell carcinoma
Q51111745	Correlation of p16 status, hypoxic imaging using [18F]-misonidazole positron emission tomography and outcome in patients with loco-regionally advanced head and neck cancer.
Q58586843	Curcumin-Mediated Degradation of S-Phase Kinase Protein 2 Induces Cytotoxic Effects in Human Papillomavirus-Positive and Negative Squamous Carcinoma Cells
Q38555889	Current role of human papillomavirus in head and neck oncology
Q58721847	Current status of clinical testing for human papillomavirus in oropharyngeal squamous cell carcinoma
Q35469459	Current trends in the etiology and diagnosis of HPV-related head and neck cancers
Q30196669	Current views and advances on Paediatric Virology: An update for paediatric trainees
Q34308828	Cyclin A1 shows age-related expression in benign tonsils, HPV16-dependent overexpression in HNSCC and predicts lower recurrence rate in HNSCC independently of HPV16
Q42204929	Cytology and human papillomavirus testing on cytobrushing samples from patients with head and neck squamous cell carcinoma.
Q93369165	Cytopathologic characteristics of HPV-related small cell carcinoma of the oropharynx
Q99605286	DNA Methylome Distinguishes Head and Neck Cancer from Potentially Malignant Oral Lesions and Healthy Oral Mucosa
Q38376361	DNA damage marker phosphorylated histone H2AX is a potential predictive marker for progression of epithelial dysplasia of the oral cavity
Q33582958	DNA microarray reveals ZNF195 and SBF1 are potential biomarkers for gemcitabine sensitivity in head and neck squamous cell carcinoma cell lines
Q98664277	DNA repair gene expression is increased in HPV positive head and neck squamous cell carcinomas
Q37010987	DNA vaccines targeting human papillomavirus-associated diseases: progresses in animal and clinical studies
Q39346340	Dangerous agent or saviour? HPV vaccine representations on online discussion forums in Romania
Q36502676	De-escalation of radiation dose for human papillomavirus-positive oropharyngeal head and neck squamous cell carcinoma: A case report and preclinical and clinical literature review
Q90485671	De-intensification for HPV positive oropharyngeal cancer: and yet it moves!: 2019 in review
Q42158194	Decision Trees Predicting Tumor Shrinkage for Head and Neck Cancer: Implications for Adaptive Radiotherapy
Q46123275	Declining oral cancer rates in Sri Lanka: are we winning the war after being at the top of the cancer league table?
Q39328588	Decreased HPV-specific T cell responses and accumulation of immunosuppressive influences in oropharyngeal cancer patients following radical therapy
Q102152436	Defining HPV-specific B cell responses in patients with head and neck cancer
Q34320362	Delineating metabolic signatures of head and neck squamous cell carcinoma: phospholipase A2, a potential therapeutic target
Q54374916	Demystifying the role of tumor HPV status in recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Q34675315	Detecting viruses by using salivary diagnostics
Q47170335	Detection of HPV related oropharyngeal cancer in oral rinse specimens
Q35475603	Detection of HPV-associated oropharyngeal tumours in a 16-year cohort: more than meets the eye.
Q34966212	Detection of Salivary Human Papilloma Viruses 16 and 18 (HPV) in Smoker Men in an Iranian Population by PCR: A Pilot Study
Q35052911	Detection of human papillomavirus (HPV) in clinical samples: evolving methods and strategies for the accurate determination of HPV status of head and neck carcinomas
Q40360475	Detection of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma using droplet digital polymerase chain reaction
Q99565815	Determining the molecular landscape and impact on prognosis in HPV-associated head and neck cancer
Q36567611	Developing Michigan Cancer Foundation 7 Cells with Stable Expression of E7 Gene of Human Papillomavirus Type 16.
Q88141317	Developing Robust Predictive Models for Head and Neck Cancer across Microarray and RNA-seq Data
Q88796642	Development and external validation of nomograms in oropharyngeal cancer patients with known HPV-DNA status: a European Multicentre Study (OroGrams)
Q33964484	Development of a PCR assay to detect papillomavirus infection in the snow leopard.
Q38267294	Development of a chemoradiation therapy toxicity staging system for oropharyngeal carcinoma
Q40504994	Diagnosis of HPV-driven head and neck cancer with a single test in routine clinical practice
Q35006777	Diagnosis of head-and-neck cancer from exhaled breath
Q38310617	Diagnostic and Management Implications of Basic Science Advances in Barrett's Esophagus
Q37633093	Differences in imaging characteristics of HPV-positive and HPV-Negative oropharyngeal cancers: a blinded matched-pair analysis
Q37655828	Differences in methylation profiles between HPV-positive and HPV-negative oropharynx squamous cell carcinoma: a systematic review.
Q40432912	Differences in survival outcome between oropharyngeal and oral cavity squamous cell carcinoma in relation to HPV status
Q36117164	Different cellular p16(INK4a) localisation may signal different survival outcomes in head and neck cancer
Q34515063	Different protein expression associated with chemotherapy response in oropharyngeal cancer according to HPV status
Q48230263	Differential diagnosis of well-differentiated squamous cell carcinoma from non-neoplastic oral mucosal lesions: New cytopathologic evaluation method dependent on keratinization-related parameters but not nuclear atypism.
Q34464484	Differential impact of IL-10 expression on survival and relapse between HPV16-positive and -negative oral squamous cell carcinomas
Q34820775	Differentiation of irradiation and cetuximab induced skin reactions in patients with locally advanced head and neck cancer undergoing radioimmunotherapy: the HICARE protocol (head and neck cancer: immunochemo and radiotherapy with erbitux) - a multi
Q56525457	Diode laser surgery in the treatment of oral proliferative verrucous leukoplakia associated with HPV-16 infection
Q35596183	Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis
Q37275499	Discussing a diagnosis of human papillomavirus oropharyngeal cancer with patients: An exploratory qualitative study of health professionals
Q38755899	Disease burden of human papillomavirus infection in the Netherlands, 1989-2014: the gap between females and males is diminishing
Q38080422	Distinct epidemiologic characteristics of oral tongue cancer patients
Q45325964	Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma
Q60922788	Distinctive Expression and Amplification of Genes at 11q13 in Relation to HPV Status with Impact on Survival in Head and Neck Cancer Patients
Q40926179	Do stigma and its psychosocial impact differ between Asian-born Chinese immigrants and Western-born Caucasians with head and neck cancer?
Q36834291	Does HPV type affect outcome in oropharyngeal cancer?
Q34282049	Dysregulation of microRNA-34a expression in head and neck squamous cell carcinoma promotes tumor growth and tumor angiogenesis
Q43041829	E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group
Q38377158	E6 and E7 Antibody Levels Are Potential Biomarkers of Recurrence in Patients with Advanced-Stage Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma
Q43603050	Economic burden of HPV-related cancers in France
Q37706274	Effect of 3q oncogenes SEC62 and SOX2 on lymphatic metastasis and clinical outcome of head and neck squamous cell carcinomas.
Q38959371	Effect of HPV on head and neck cancer patient survival, by region and tumor site: A comparison of 1362 cases across three continents
Q40871740	Effect of HPV on tumor expression levels of the most commonly used markers in HNSCC.
Q39877713	Effect of actionable somatic mutations on racial/ethnic disparities in head and neck cancer prognosis.
Q50927368	Effector memory T-cell frequencies in relation to tumour stage, location and HPV status in HNSCC patients.
Q35535744	Effects of ERCC2 Lys751Gln (A35931C) and CCND1 (G870A) polymorphism on outcome of advanced-stage squamous cell carcinoma of the head and neck are treatment dependent
Q56904286	Emerging and re-emerging infectious disease in otorhinolaryngology
Q38268896	Emerging biomarkers in head and neck cancer in the era of genomics.
Q40046181	Emerging insights into recurrent and metastatic human papillomavirus-related oropharyngeal squamous cell carcinoma
Q59478544	Employment and return to work following chemoradiation in patient with HPV-related oropharyngeal cancer
Q38724085	Epidemiological Trends of Head and Neck Cancer in the United States: A SEER Population Study
Q36088074	Epidemiology and clinical aspects of HPV in head and neck cancers
Q40377873	Epithelial to mesenchymal transition and HPV infection in squamous cell oropharyngeal carcinomas: the papillophar study
Q36407378	Equivocal p16 immunostaining in squamous cell carcinoma of the head and neck: staining patterns are suggestive of HPV status
Q38898269	Establishment of a novel human papillomavirus-negative and radiosensitive head and neck squamous cell carcinoma cell line
Q89506997	Establishment of epigenetic markers to predict irradiation efficacy against oropharyngeal cancer
Q90437590	Estrogen Attenuates the Growth of Human Papillomavirus-Positive Epithelial Cells
Q35856514	Evaluation of a combined triple method to detect causative HPV in oral and oropharyngeal squamous cell carcinomas: p16 Immunohistochemistry, Consensus PCR HPV-DNA, and In Situ Hybridization
Q59357202	Evaluation of pemetrexed and etoposide as therapeutic regimens for human papillomavirus-positive oral and oropharyngeal cancer
Q37906380	Evidence for a causal association for HPV in head and neck cancers
Q64921365	Evidence on the prevalence, incidence, mortality and trends of human papilloma virus-associated cancers in sub-Saharan Africa: systematic scoping review.
Q42748177	Exploring the implications of HPV infection for head and neck cancer
Q37299934	Expression of EGFR, VEGF, and NOTCH1 suggest differences in tumor angiogenesis in HPV-positive and HPV-negative head and neck squamous cell carcinoma
Q35863172	Expression of p16 in squamous cell carcinoma of the mobile tongue is independent of HPV infection despite presence of the HPV-receptor syndecan-1
Q36091797	Expression of p53, p21(CIP1/WAF1) and eIF4E in the adjacent tissues of oral squamous cell carcinoma: establishing the molecular boundary and a cancer progression model
Q33819012	FDG PET/CT imaging of oropharyngeal squamous cell carcinoma: characteristics of human papillomavirus-positive and -negative tumors
Q40305507	Family history of cancer and head and neck cancer survival
Q46694539	FcGBP was upregulated by HPV infection and correlated to longer survival time of HNSCC patients
Q39552776	Fine-needle aspiration of cervical lymph nodes yields adequate materials for accurate HPV testing in metastatic head and neck squamous cell carcinomas
Q55100728	Frequency of HPV in oral cavity squamous cell carcinoma.
Q34275134	Fusion of CTLA-4 with HPV16 E7 and E6 enhanced the potency of therapeutic HPV DNA vaccine
Q33963901	GRIM-19 disrupts E6/E6AP complex to rescue p53 and induce apoptosis in cervical cancers
Q38074368	Gastrostomy tube placement in patients with oropharyngeal carcinoma treated with radiotherapy or chemoradiotherapy: factors affecting placement and dependence
Q36430737	Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma.
Q30783749	Genetic variants in DNA repair pathways and risk of upper aerodigestive tract cancers: combined analysis of data from two genome-wide association studies in European populations
Q37626448	Genetic variants in TNF-α promoter are predictors of recurrence in patients with squamous cell carcinoma of oropharynx after definitive radiotherapy
Q40147257	Genetic variants in microRNA-binding sites of DNA repair genes as predictors of recurrence in patients with squamous cell carcinoma of the oropharynx
Q34252925	Genetic variants of NOXA and MCL1 modify the risk of HPV16-associated squamous cell carcinoma of the head and neck
Q35888539	Genetic variants of a BH3-only pro-apoptotic gene, PUMA, and risk of HPV16-associated squamous cell carcinoma of the head and neck
Q28391355	Genome stability pathways in head and neck cancers
Q38874178	Geographic heterogeneity in the prevalence of human papillomavirus in head and neck cancer
Q41640485	Global burden of human papillomavirus-positive head and neck cancers
Q22241238	Global cancer statistics
Q101404500	HIF-1a expression and differential effects on survival in patients with oral cavity, larynx, and oropharynx squamous cell carcinomas
Q40827858	HPV 16 E7 inhibits OSCC cell proliferation, invasion, and metastasis by upregulating the expression of miR-20a
Q26741386	HPV Associated Head and Neck Cancer
Q55333361	HPV E6 oncoproteins and nucleic acids in neck lymph node fine needle aspirates and oral samples from patients with oropharyngeal squamous cell carcinoma.
Q37689493	HPV Infection in Cervical and Other Cancers in Saudi Arabia: Implication for Prevention and Vaccination
Q36645480	HPV Population Profiling in Healthy Men by Next-Generation Deep Sequencing Coupled with HPV-QUEST.
Q89170715	HPV RNA CISH score identifies two prognostic groups in a p16 positive oropharyngeal squamous cell carcinoma population
Q28081656	HPV and cancer of the oral cavity
Q28652424	HPV clearance and the neglected role of stochasticity
Q39189397	HPV in Larynx Squamous Cell Carcinoma: New Serotypes and Survival Study within 10-Year Follow-up
Q26853669	HPV in oropharyngeal cancer: the basics to know in clinical practice
Q47801016	HPV infection and P16 expression in oral and oropharyngeal cancer in Kazakhstan
Q36746765	HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker?
Q47106612	HPV infection in the oral cavity: epidemiology, clinical manifestations and relationship with oral cancer
Q36088094	HPV specific testing: a requirement for oropharyngeal squamous cell carcinoma patients
Q35916686	HPV status is associated with altered PIWI-interacting RNA expression pattern in head and neck cancer.
Q35995194	HPV-16/18 detection does not affect the prognosis of head and neck squamous cell carcinoma in younger and older patients.
Q40875373	HPV-Associated Head and Neck Cancer
Q52597650	HPV-Induced Field Cancerisation: Transformation of Adult Tissue Stem Cell Into Cancer Stem Cell.
Q40425719	HPV-Positive Oropharyngeal Cancer Via p16 Immunohistochemistry in Japan
Q38971543	HPV-Related Head and Neck Squamous Cell Carcinomas
Q64963619	HPV-driven oropharyngeal cancer: current knowledge of molecular biology and mechanisms of carcinogenesis.
Q104475857	HPV-inactive cell populations arise from HPV16-transformed human keratinocytes after p53 knockout
Q47593658	HPV-negative, but not HPV-positive, oropharyngeal carcinomas induce fibroblasts to support tumour invasion through micro-environmental release of HGF and IL-6.
Q42234403	HPV-related cervical disease and oropharyngeal cancer
Q27852254	HPV-related methylation signature predicts survival in oropharyngeal squamous cell carcinomas
Q92539747	HPV-related oropharyngeal cancer prevalence in a middle eastern population using E6/E7 PCR
Q36416456	HPV-related oropharyngeal carcinoma with Overt Level II and/or III metastases at presentation: The risk of subclinical disease in ipsilateral levels IB, IV and V.
Q39225062	HPV-transgenic mouse models: Tools for studying the cancer-associated immune response.
Q35672982	HPV16 Down-Regulates the Insulin-Like Growth Factor Binding Protein 2 to Promote Epithelial Invasion in Organotypic Cultures
Q36573652	HPV16 E6 and E7 proteins induce a chronic oxidative stress response via NOX2 that causes genomic instability and increased susceptibility to DNA damage in head and neck cancer cells
Q35688600	HPV16 antibodies as risk factors for oropharyngeal cancer and their association with tumor HPV and smoking status
Q34621821	Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers.
Q50222033	Head and neck cancer in South Asia: Macroeconomic consequences and the role of the head and neck surgeon.
Q66475935	Head and neck cancer in World Trade Center responders: a case series
Q36117934	Head and neck cancer: effective prevention in youth and predictive diagnostics for personalised treatment strategies according to biological differences
Q38082457	Head and neck cancer: from anatomy to biology
Q41743538	Head and neck second primary cancer rates in the human papillomavirus era: A population-based analysis.
Q37366359	Helical tomotherapy: an innovative radiotherapy technique for the treatment of locally advanced oropharynx and inoperable oral cavity carcinoma
Q90059007	Heterogeneity of p16 immunohistochemistry and increased sensitivity of RNA in situ hybridization in cytology specimens of HPV-related head and neck squamous cell carcinoma
Q50066385	Hh-Gli signaling pathway activity in oral and oropharyngeal squamous cell carcinoma.
Q38645976	High Risk Alpha Papillomavirus Oncogenes Impair the Homologous Recombination Pathway
Q34065359	High prevalence of HPV in non-cervical sites of women with abnormal cervical cytology
Q91127276	High-risk HPV and neuroendocrine carcinomas of the head and neck
Q37093537	High-risk HPV is not associated with epithelial ovarian cancer in a Caucasian population
Q83836704	High-risk human papillomavirus in nasopharyngeal carcinoma
Q37106973	Highly aggressive human papillomavirus-related oropharyngeal cancer: clinical, radiologic, and pathologic characteristics
Q37425877	Histological subtypes and characteristic structures of HPV-associated oropharyngeal carcinoma: study with Japanese cases
Q42276180	How Much Do Italian Patients in Supportive Periodontal Therapy Know about the Role of Smoking in Oral Health and What is Their Lifestyle?
Q38869435	Human Papilloma Virus as a Biomarker for Personalized Head and Neck Cancer Radiotherapy
Q40441462	Human Papilloma Virus in Oral Cavity Cancer and Relation to Change in Quality of Life Following Treatment-a Pilot Study from Northern India
Q26822621	Human Papillomavirus (HPV)-associated Oral Cancers and Treatment Strategies
Q90287185	Human Papillomavirus 16 E2 Regulates Keratinocyte Gene Expression Relevant to Cancer and the Viral Life Cycle
Q93116731	Human Papillomavirus 16 oncoprotein E7 retards mitotic progression by blocking Mps1-MAP4 signaling cascade
Q39125435	Human Papillomavirus Associated Cancers of the Head and Neck: An Australian Perspective.
Q40406103	Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV+ Patients
Q40736348	Human Papillomavirus Vaccination Counseling in Pediatric Training: Are We Discussing Otolaryngology-Related Manifestations?
Q55385410	Human Papillomavirus and Oropharyngeal Cancer Among Indigenous Australians: Protocol for a Prevalence Study of Oral-Related Human Papillomavirus and Cost-Effectiveness of Prevention.
Q58587244	Human Papillomavirus in Head and Neck Squamous Cell Carcinomas in a South African Cohort
Q42242155	Human papilloma virus detection and typing in 334 lung cancer patients
Q37789092	Human papilloma virus in locally advanced stage III/IV squamous cell cancer of the oropharynx and impact on choice of therapy
Q37000170	Human papilloma virus prevalence in a multiethnic screening population
Q92003125	Human papilloma virus-associated metachronous squamous cell carcinoma of the larynx and uterine cervix: Case report and review of the literature
Q60620818	Human papillomavirus (HPV) and its vaccine: awareness and opinions of clinical dental students in a UK dental school
Q37605241	Human papillomavirus (HPV) deregulation of Toll-like receptor 9.
Q38149673	Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States--do we need a broader vaccine policy?
Q98895322	Human papillomavirus 16-positive supraclavicular cutaneous squamous cell carcinoma metastatic to the level IV supraclavicular lymph nodes
Q37481203	Human papillomavirus DNA and p16 expression in Japanese patients with oropharyngeal squamous cell carcinoma.
Q39145678	Human papillomavirus DNA detection in fine-needle aspirates as indicator of human papillomavirus-positive oropharyngeal squamous cell carcinoma: A prospective study
Q38064067	Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis
Q84066318	Human papillomavirus and oral squamous cell carcinoma in a south Brazilian population
Q33778119	Human papillomavirus and oropharyngeal cancer, the epidemics, and significance of additional clinical biomarkers for prediction of response to therapy (Review).
Q38023262	Human papillomavirus and oropharyngeal squamous cell carcinoma: what the clinician should know
Q35051410	Human papillomavirus and p53 mutations in head and neck squamous cell carcinoma among Japanese population
Q46762989	Human papillomavirus and survival in patients with base of tongue cancer
Q35232819	Human papillomavirus and tonsillar and base of tongue cancer
Q47095041	Human papillomavirus associated head and neck squamous cell carcinoma: Controversies and new concepts
Q34608088	Human papillomavirus genotype distribution in tonsil cancers
Q42364839	Human papillomavirus in head and neck cancer in India: Current status and consensus recommendations
Q34450121	Human papillomavirus in head and neck squamous cell carcinoma of unknown primary is a common event and a strong predictor of survival
Q44878905	Human papillomavirus in squamous cell cancer of the head and neck. A study at the Ulm Military Hospital, Germany
Q90218755	Human papillomavirus infection among head and neck squamous cell carcinomas in southern China
Q35920904	Human papillomavirus infection and biomarkers in sinonasal inverted papillomas: clinical significance and molecular mechanisms
Q38979260	Human papillomavirus infection and p16 overexpression in oropharyngeal squamous cell carcinoma: a case series from 2010 to 2014.
Q34764776	Human papillomavirus infection in 674 Chinese patients with laryngeal squamous cell carcinoma
Q43777296	Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study
Q36824384	Human papillomavirus prevalence and cell cycle related protein expression in tonsillar squamous cell carcinomas of korean patients with clinicopathologic analysis
Q38410170	Human papillomavirus status in young patients with head and neck squamous cell carcinoma.
Q35052898	Human papillomavirus status of head and neck cancer as determined in cytologic specimens using the hybrid-capture 2 assay
Q37848732	Human papillomavirus vaccination in males: the state of the science
Q36750553	Human papillomavirus vaccination induces neutralising antibodies in oral mucosal fluids
Q37650660	Human papillomavirus, p16(INK4A), and Ki-67 in relation to clinicopathological variables and survival in primary carcinoma of the vagina
Q34342397	Human papillomavirus-16 infection in advanced oral cavity cancer patients is related to an increased risk of distant metastases and poor survival
Q46166819	Human papillomavirus-associated oral intraepithelial neoplasia
Q40701232	Human papillomavirus-related oropharyngeal cancer in the HIV-infected population
Q35354701	Human papillomavirus-related small cell carcinoma of the oropharynx
Q41239999	Hybrid Capture 2 human papillomavirus testing of fine needle aspiration cytology of head and neck squamous cell carcinomas
Q96304645	Identification of Hub Genes Associated With Development of Head and Neck Squamous Cell Carcinoma by Integrated Bioinformatics Analysis
Q37265632	Identification of RNA aptamers that internalize into HPV-16 E6/E7 transformed tonsillar epithelial cells
Q35143770	Identification of a human papillomavirus-associated oncogenic miRNA panel in human oropharyngeal squamous cell carcinoma validated by bioinformatics analysis of the Cancer Genome Atlas
Q38724749	Identification of human papillomavirus (HPV) 16 DNA integration and the ensuing patterns of methylation in HPV-associated head and neck squamous cell carcinoma cell lines
Q47567613	Identification of human papillomavirus (HPV) subtype in oral cancer patients through microarray technology
Q42219387	Identification of human papillomavirus status specific biomarker in head and neck cancer.
Q37024527	Identifying the risk factors for late-stage head and neck cancer
Q34723594	Immune biomarkers of anti-EGFR monoclonal antibody therapy
Q41500273	Immunohistochemical biomarkers and FDG uptake on PET/CT in head and neck squamous cell carcinoma
Q37478281	Immunotherapy in new pre-clinical models of HPV-associated oral cancers
Q88641314	Impact of Age on Disease Progression and Microenvironment in Oral Cancer
Q36193668	Impact of Compliance on Dysphagia Rehabilitation in Head and Neck Cancer Patients: Results from a Multi-center Clinical Trial
Q37718270	Impact of HPV infection on oral squamous cell carcinoma
Q34768545	Impact of HPV infection on the clinical outcome of p-CAIR trial in head and neck cancer
Q37371401	Impact of HPV infection on the development of head and neck cancer
Q90356445	Impact of anatomic origin of primary squamous cell carcinomas of the nasal cavity and ethmoidal sinus on clinical outcome
Q96609636	Impact of genetic variants in clinical outcome of a cohort of patients with oropharyngeal squamous cell carcinoma
Q36263185	Impact of human papillomavirus on head and neck squamous cell cancers in Gabon
Q37087450	Impact of human papillomavirus on oropharyngeal cancer biology and response to therapy: implications for treatment
Q90842277	Impact of human papillomavirus status on survival and recurrence in a geographic region with a low prevalence of HPV-related cancer: A retrospective cohort study
Q39543776	Impact of p16 expression in oropharyngeal cancer in the postoperative setting: the necessity of re-evaluating traditional risk stratification.
Q42282859	Impact of the HPV-positivity definition on the prognostic value of HPV status in patients with locally advanced squamous cell carcinoma of the head and neck
Q43216545	Implications of the oropharyngeal cancer epidemic
Q36879225	Improved clearance during treatment of HPV-positive head and neck cancer through mTOR inhibition.
Q35258785	Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis.
Q36815283	Improved survival with HPV among African Americans with oropharyngeal cancer
Q38867095	In vitro 3-dimensional tumor model for radiosensitivity of HPV positive OSCC cell lines
Q37524405	Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study.
Q38215252	Incidence and clinical management of oral human papillomavirus infection in men: a series of key short messages
Q51876731	Incidence of human papillomavirus-related oropharyngeal cancer and outcomes after chemoradiation in a population of heavy smokers.
Q31159720	Incidence trends for potentially human papillomavirus-related and -unrelated head and neck cancers in France using population-based cancer registries data: 1980-2012.
Q47595604	Incidence trends in head and neck cancers and human papillomavirus (HPV)-associated oropharyngeal cancer in Canada, 1992-2009.
Q89868207	Inclusion of an E7 DNA Amplification Test Improves the Robustness of Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma Diagnosis
Q36172627	Increased Expression of HER2, HER3, and HER2:HER3 Heterodimers in HPV-Positive HNSCC Using a Novel Proximity-Based Assay: Implications for Targeted Therapies
Q50484749	Increased prevalence of tumour infiltrating immune cells in oropharyngeal tumours in comparison to other subsites: relationship to peripheral immunity.
Q38735678	Increased survival rate by local release of diclofenac in a murine model of recurrent oral carcinoma
Q94599675	Increasing incidence and improving survival of oral tongue squamous cell carcinoma
Q43564259	Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm.
Q39211092	Indicators for Enteral Nutrition Use and Prophylactic Percutaneous Endoscopic Gastrostomy Placement in Patients With Head and Neck Cancer Undergoing Chemoradiotherapy
Q35602143	Induction therapy with cetuximab plus docetaxel, cisplatin, and 5-fluorouracil (ETPF) in patients with resectable nonmetastatic stage III or IV squamous cell carcinoma of the oropharynx. A GERCOR phase II ECHO-07 study
Q35913813	Infiltrating lymphocytes and human papillomavirus-16--associated oropharyngeal cancer
Q50271390	Influence of social factors on patient-reported late symptoms: Report from a controlled trial among long-term head and neck cancer survivors in Denmark
Q51034156	Informational and Support Needs of Patients with Head and Neck Cancer: Current Status and Emerging Issues.
Q48159682	Inhibition of JAK2/STAT3 reduces tumor-induced angiogenesis and myeloid-derived suppressor cells in head and neck cancer.
Q45165554	Innate immune reactions in locally limited tonsillar cancer
Q57475463	Innate immunity and HPV: friends or foes
Q94465294	Integrated Non-targeted and Targeted Metabolomics Uncovers Amino Acid Markers of Oral Squamous Cell Carcinoma
Q37055212	Interferon Inducible IFI16 Expression in p16 Positive Squamous Cell Carcinoma of the Oropharynx
Q36860338	Interleukin-10 promoter variants predict HPV-positive tumors and survival of squamous cell carcinoma of the oropharynx
Q28650140	Intra-tumor genetic heterogeneity and mortality in head and neck cancer: analysis of data from the Cancer Genome Atlas
Q36856259	Intranodal cystic changes: a potential radiologic signature/biomarker to assess the human papillomavirus status of cases with oropharyngeal malignancies
Q55116921	Intraoral Potentially Malignant Disorders in a Brazilian Oral Pathology Service: Epidemiological, Clinical, and Histopathological Findings.
Q52902619	Investigation of p16 status, chemotherapy regimen, and other nutrition markers for predicting gastrostomy in patients with head and neck cancer.
Q50935974	Investigation of the presence of HPV related oropharyngeal and oral tongue squamous cell carcinoma in Mozambique.
Q94457714	Investigation of viral etiology in potentially malignant disorders and oral squamous cell carcinomas in non-smoking, non-drinking patients
Q34499329	Involvement of aryl hydrocarbon receptor signaling in the development of small cell lung cancer induced by HPV E6/E7 oncoproteins
Q47610361	Is Lipidomic the Answer to the Search of a Biomarker for Organ Preservation Protocol in Head and Neck Squamous Cell Carcinoma?
Q40219648	Is immunohistochemical evaluation of p16 in oropharyngeal cancer enough to predict the HPV positivity?
Q54216107	KF-finder: identification of key factors from host-microbial networks in cervical cancer.
Q90250942	LCL161, a SMAC-mimetic, Preferentially Radiosensitizes Human Papillomavirus-negative Head and Neck Squamous Cell Carcinoma
Q36311573	Laboratory and clinical aspects of human papillomavirus testing
Q40174218	Lack of HPV in Benign and Malignant Epithelial Ovarian Tumors in Iran
Q54287199	Lack of evidence for an association between seminoma and human papillomavirus infection using GP5+/GP6+ consensus primers.
Q86850198	Late follow-up of the randomized radiation and concomitant high-dose intra-arterial or intravenous cisplatin (RADPLAT) trial for advanced head and neck cancer
Q64892744	Logistic regression prediction model identify type 2 diabetes mellitus as a prognostic factor for human papillomavirus-16 associated head and neck squamous cell carcinoma.
Q91562913	Long-term opioid use in curative-intent radiotherapy: One-Year outcomes in head/neck cancer patients
Q35163993	Long-term persistence of oral human papillomavirus type 16: the HPV Infection in Men (HIM) study
Q37209937	Long-term prognosis and risk factors among patients with HPV-associated oropharyngeal squamous cell carcinoma
Q42197987	Low prevalence of human papillomavirus in head and neck squamous cell carcinoma in Chinese patients
Q36281407	Low prevalence of human papillomavirus in head and neck squamous cell carcinoma in the northwest region of the Philippines.
Q36605100	MATH, a novel measure of intratumor genetic heterogeneity, is high in poor-outcome classes of head and neck squamous cell carcinoma
Q58564422	Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trial
Q50712081	Management of neck metastases of unknown primary origin united in two European centers.
Q64950560	Mapping of human papilloma virus, p16, and epstein-barr virus in non-malignant tonsillar disease.
Q42215016	Mass media coverage of HPV vaccination in Romania: a content analysis
Q36179702	Matted nodes: poor prognostic marker in oropharyngeal squamous cell carcinoma independent of HPV and EGFR status
Q40341987	Measured Adiposity in Relation to Head and Neck Cancer Risk in the European Prospective Investigation into Cancer and Nutrition
Q38557897	Meta-analysis of survival in patients with HNSCC discriminates risk depending on combined HPV and p16 status
Q36778066	Metastatic squamous cell carcinoma to the brain: an unrecognized pattern of distant spread in patients with HPV-related head and neck cancer
Q35834637	MicroRNA-363 targets myosin 1B to reduce cellular migration in head and neck cancer
Q34595170	Microbiota in the Throat and Risk Factors for Laryngeal Carcinoma
Q42244844	Misregulation of DNA damage repair pathways in HPV-positive head and neck squamous cell carcinoma contributes to cellular radiosensitivity
Q36941427	Modifiable risk behaviors in patients with head and neck cancer
Q28082815	Molecular Aspects of Head and Neck Cancer Therapy
Q38069455	Molecular and cellular processes underlying the hallmarks of head and neck cancer.
Q37000422	Molecular characterization of head and neck cancer: how close to personalized targeted therapy?
Q38087239	Molecular diagnostic alterations in squamous cell carcinoma of the head and neck and potential diagnostic applications
Q91886062	Molecular dissection of the oncogenic role of ETS1 in the mesenchymal subtypes of head and neck squamous cell carcinoma
Q90092792	Molecular mechanisms underlying increased radiosensitivity in human papillomavirus-associated oropharyngeal squamous cell carcinoma
Q48330842	Morphologic and topographic radiologic features of human papillomavirus-related and -unrelated oropharyngeal carcinoma.
Q42059681	Morphologic diversity in human papillomavirus-related oropharyngeal squamous cell carcinoma: Catch Me If You Can!
Q41035814	Mouth Cancer for Clinicians Part 5: Risk Factors (Other).
Q34098286	Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss
Q47696257	Multifocal human papillomavirus detection in palatine and pharyngeal tonsils
Q35827866	NDN and CD1A are novel prognostic methylation markers in patients with head and neck squamous carcinomas.
Q27347744	NHANES 2009-2012 Findings: Association of Sexual Behaviors with Higher Prevalence of Oral Oncogenic Human Papillomavirus Infections in U.S. Men
Q64274770	Natural history of human papillomavirus and vaccinations in men: A literature review
Q42224729	Negative human papillomavirus status and excessive alcohol consumption are significant risk factors for second primary malignancies in Japanese patients with oropharyngeal carcinoma.
Q93026726	Neutrophils infiltration and its correlation with human papillomavirus status in the oral squamous cell carcinoma
Q38015390	New Concepts for Translational Head and Neck Oncology: Lessons from HPV-Related Oropharyngeal Squamous Cell Carcinomas
Q50336126	New developments in the management of head and neck cancer – impact of pembrolizumab
Q36880375	New insights into human papillomavirus-associated head and neck squamous cell carcinoma
Q38128210	New treatment strategies for HPV-positive head and neck cancer
Q36558569	Newly Described Tumor Entities in Sinonasal Tract Pathology.
Q37943790	Next-generation treatment strategies for human papillomavirus-related head and neck squamous cell carcinoma: where do we go?
Q37541278	No Detection of Episomal or Integrated High-Risk Human Papillomavirus in Nonsmall Cell Lung Carcinomas among Korean Population.
Q40596292	No role for human papillomavirus infection in oral cancers in a region in southern India
Q38112573	Non-AIDS-defining cancers among HIV-infected patients
Q47096307	Non-coding RNAs profiling in head and neck cancers.
Q62561917	Novel biophysical determination of miRNAs related to prostate and head and neck cancers
Q37687705	Novel nomograms for survival and progression in HPV+ and HPV- oropharyngeal cancer: a population-based study of 1,542 consecutive patients
Q37593461	Nuances in the changing epidemiology of head and neck cancer
Q37716457	Nuclear PRMT5, cyclin D1 and IL-6 are associated with poor outcome in oropharyngeal squamous cell carcinoma patients and is inversely associated with p16-status
Q38896229	Number of positive nodes is superior to the lymph node ratio and American Joint Committee on Cancer N staging for the prognosis of surgically treated head and neck squamous cell carcinomas
Q42219702	Occult Primary Head and Neck Squamous Cell Carcinoma: Utility of Discovering Primary Lesions.
Q40046605	Oncogenic human papillomaviruses
Q40713738	Oncologic outcomes of surgically treated early-stage oropharyngeal squamous cell carcinoma
Q38729256	Online support groups for head and neck cancer and health-related quality of life.
Q38545129	Oral Cancer and Oral Precancerous Lesions in Inflammatory Bowel Diseases: A Systematic Review
Q93036197	Oral HPV prevalence and HPV vaccination among special needs population in the US
Q50956560	Oral and oropharyngeal squamous cell carcinoma in young patients: the Netherlands Cancer Institute experience.
Q24617682	Oral cancer, HPV infection and evidence of sexual transmission
Q35936744	Oral cavity and pharynx cancer incidence trends by subsite in the United States: changing gender patterns
Q90211108	Oral gargle-tumor biopsy human papillomavirus (HPV) agreement and associated factors among oropharyngeal squamous cell carcinoma (OPSCC) cases
Q33801273	Oral manifestations of hepatitis C virus infection
Q27693327	Oral premalignancy: the roles of early detection and chemoprevention
Q41658902	Oral prevalence and clearance of oncogenic human papilloma virus in a rehabilitation community for substance abusers in Italy: a case of behavioral correction?
Q53284986	Oral squamous cell carcinoma versus oral verrucous carcinoma: an approach to cellular proliferation and negative relation to human papillomavirus (HPV).
Q37437713	Oral squamous cell carcinoma: clinicopathological features from 346 cases from a single oral pathology service during an 8-year period
Q35804927	Oropharyngeal Cancer Epidemic and Human Papillomavirus
Q38674531	Oropharyngeal cancer and human papilloma virus: evolving diagnostic and management paradigms.
Q42285826	Oropharyngeal cancer related to Human Papilloma Virus: incidence and prognosis in Madrid, Spain.
Q38195721	Oropharyngeal squamous cell carcinoma treatment: current standards and future directions
Q37797729	Oropharyngeal squamous cell carcinoma: A unique disease on the rise?
Q36823719	Oropharyngeal squamous cell carcinomas differentially express granzyme inhibitors
Q59351954	Otolaryngologists and their role in vaccination for prevention of HPV associated head & neck cancer
Q98166028	Outcomes after primary intensity-modulated radiation therapy for oropharyngeal squamous cell carcinoma at a New Zealand regional cancer centre: Impact of p16 status
Q38171835	P16INK4A as a surrogate biomarker for human papillomavirus-associated oropharyngeal carcinoma: consideration of some aspects
Q34079274	P53 nuclear stabilization is associated with FHIT loss and younger age of onset in squamous cell carcinoma of oral tongue
Q89368220	Patients with early-stage oropharyngeal cancer can be identified with label-free serum proteomics
Q88816165	Patterns of Tobacco Cessation Attempts and Symptoms Experienced Among Smokers With Head and Neck Squamous Cell Carcinoma
Q35372786	Patterns of care and perioperative outcomes in transoral endoscopic surgery for oropharyngeal squamous cell carcinoma
Q42254154	Performance of the Roche cobas 4800 high-risk human papillomavirus test in cytologic preparations of squamous cell carcinoma of the head and neck
Q35553791	Phase I study of vandetanib with radiation therapy with or without cisplatin in locally advanced head and neck squamous cell carcinoma
Q53069350	Photoacoustic Imaging as an Early Biomarker of Radio Therapeutic Efficacy in Head and Neck Cancer.
Q41858791	Pocket proteins suppress head and neck cancer
Q35066932	Polymorphisms of the XPC gene may contribute to the risk of head and neck cancer: a meta-analysis
Q92060396	Potential of Pembrolizumab in Metastatic or Recurrent Head and Neck Cancer: Evidence to Date
Q47677262	Pre-diagnostic dynamic HPV16 IgG seropositivity and risk of oropharyngeal cancer
Q55012383	Precision Medicine in Head and Neck Cancer: Myth or Reality?
Q36482413	Prediction of Lymph Node Metastasis by Tumor Dimension Versus Tumor Biological Properties in Head and Neck Squamous Cell Carcinomas
Q38182948	Predictive accuracy of first post-treatment PET/CT in HPV-related oropharyngeal squamous cell carcinoma
Q27690755	Predictive value of epigenetic alterations in head and neck squamous cell carcinoma
Q50078313	Predictors of Clinicopathologic Stage Discrepancy in Oropharyngeal Squamous Cell Carcinoma: A National Cancer Database Study
Q59352457	Presence and activity of HPV in primary lung cancer
Q44817366	Presence of human papillomaviruses and p16 expression in hypopharyngeal cancer
Q90134818	Prevalence and Detection of Sexually Transmitted Cases of Laryngeal Carcinoma
Q36253884	Prevalence and Determinants of Oral Human Papillomavirus Infection in 500 Young Adults from Italy.
Q58827180	Prevalence and Epidemiologic Profile of Oral Infection with Alpha, Beta, and Gamma Papillomaviruses in an Asian Chinese Population
Q90412959	Prevalence and Impact of Human Papillomavirus on Head and Neck Cancers: Review of Indian Studies
Q58602116	Prevalence and concordance of oral and genital HPV in women positive for cervical HPV infection and in their sexual stable partners: An Italian screening study
Q44176293	Prevalence of HPV infection in hypopharyngeal and laryngeal squamous cell carcinoma at Thailand's largest tertiary referral center
Q92755697	Prevalence of Human Papillomavirus (HPV) Infection and the Association with Survival in Saudi Patients with Head and Neck Squamous Cell Carcinoma
Q40054082	Prevalence of Human Papillomavirus in Benign and Malignant Laryngeal Lesions in Egyptian Patients: Cross-Sectional Study
Q96231374	Prevalence of human papillomavirus in sinonasal squamous cell carcinoma with and without association of inverted papilloma in Eastern China
Q98290550	Primary chemoradiation with cisplatin versus cetuximab for locally advanced head and neck cancer: a retrospective cohort study
Q26995360	Profiling invasiveness in head and neck cancer: recent contributions of genomic and transcriptomic approaches
Q54288891	Prognostic impact of human papillomavirus status, survivin, and epidermal growth factor receptor expression on survival in patients treated with radiochemotherapy for very advanced nonresectable oropharyngeal cancer.
Q55717696	Prognostic role of c-Met in head and neck squamous cell cancer tissues: a meta-analysis.
Q48225967	Prognostic significance of E-cadherin and β-catenin expression in HPV-negative oropharyngeal squamous cell carcinomas
Q41684875	Prognostic value of p16 expression irrespective of human papillomavirus status in patients with oropharyngeal carcinoma
Q39842946	Programmable protein arrays for immunoprofiling HPV-associated cancers
Q90239943	Promoter Hypermethylation of Tumor-Suppressor Genes p16INK4a, RASSF1A, TIMP3, and PCQAP/MED15 in Salivary DNA as a Quadruple Biomarker Panel for Early Detection of Oral and Oropharyngeal Cancers
Q35467512	Prophylactic cancer vaccination by targeting functional non-self
Q90723046	Protecting Tumors by Preventing Human Papilloma Virus Antigen Presentation: Insights from Emerging Bioinformatics Algorithms
Q86490397	Protein expression and promoter methylation of the candidate biomarker TCF21 in head and neck squamous cell carcinoma
Q35236494	Proteomic analysis of oral cavity squamous cell carcinoma specimens identifies patient outcome-associated proteins
Q35214908	Proton pump inhibitors and histamine 2 blockers are associated with improved overall survival in patients with head and neck squamous carcinoma
Q90606447	Proton versus photon radiation-induced cell death in head and neck cancer cells
Q36653046	Psychological factors associated with head and neck cancer treatment and survivorship: evidence and opportunities for behavioral medicine
Q41143814	Public awareness of human papillomavirus as a causative factor for oropharyngeal cancer.
Q90054104	Quality of Life, Anxiety, and Depression in the Head-and-Neck Cancer Patients, Undergoing Intensity-Modulated Radiotherapy Treatment
Q39134863	Quantifying the Dynamics of Field Cancerization in Tobacco-Related Head and Neck Cancer: A Multiscale Modeling Approach
Q104585461	Quantitative assessment of p16 expression in FNA specimens from head and neck squamous cell carcinoma and correlation with HPV status
Q40385990	Race and sex disparities in long-term survival of oral and oropharyngeal cancer in the United States
Q38859472	Racial differences in head and neck squamous cell carcinomas among non-Hispanic black and white males identified through the National Cancer Database (1998-2012).
Q36400010	Racial disparity in oral and pharyngeal cancer in Florida in 1991-2008: mixed trends in stage of diagnosis
Q60920496	Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial
Q91906187	Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus
Q42380325	Refining prognostic stratification of human papillomavirus-related oropharyngeal squamous cell carcinoma: different prognosis between T1 and T2.
Q35814887	Regional recurrence of oropharyngeal cancer after definitive radiotherapy: a case control study
Q59358242	Relationship Between p16 Expression and Prognosis in Patients with Oropharyngeal Cancer Undergoing Surgery
Q36370394	Relationship between CK19 expression, deregulation of normal keratinocyte differentiation pattern and high risk-human papilloma virus infection in oral and oropharyngeal squamous cell carcinoma
Q42226895	Relationship between insulin-like growth factor-1 receptor and human papillomavirus in patients with oropharyngeal cancer
Q92296438	Repression of AXL expression by AP-1/JNK blockage overcomes resistance to PI3Ka therapy
Q45345081	Retropharyngeal lymph node dissection in oropharyngeal cancer treated with transoral robotic surgery.
Q89858052	Return to work after oropharyngeal cancer treatment-Highlighting a growing working-age population
Q41592768	Rising prevalence of human papillomavirus-related oropharyngeal cancer in Australia over the last 2 decades
Q38971539	Risk Factors for Oral Infection with Human Papillomavirus.
Q43588955	Risk factors for non-cancer health events in patients with head and neck squamous cell carcinoma
Q40094492	Risk of cancer in patients with genital warts: A nationwide, population-based cohort study in Taiwan
Q50795914	Risk of second primary cancer after a first potentially-human papillomavirus-related cancer: A population-based study.
Q90471724	Risk of second primary malignancies in head and neck cancer patients treated with definitive radiotherapy
Q34778909	Risk of vertical transmission of human papillomavirus throughout pregnancy: a prospective study
Q57162424	Robotics in otorhinolaryngology - head and neck surgery
Q42232860	Role of Human Papillomavirus in the Pathogenesis of Laryngeal Dysplasia.
Q41934682	Role of Viruses in Gastrointestinal cancer
Q33770030	Role of human papillomavirus in oropharyngeal squamous cell carcinoma: A review.
Q36614198	Role of infectious agents in the carcinogenesis of brain and head and neck cancers
Q55502790	Role of mucosal high-risk human papillomavirus types in head and neck cancers in Romania.
Q38859808	Role of mucosal high-risk human papillomavirus types in head and neck cancers in central India
Q57667350	Runs of homozygosity and a cluster of vulvar cancer in young Australian Aboriginal women
Q95831737	SATB1 as oncogenic driver and potential therapeutic target in head & neck squamous cell carcinoma (HNSCC)
Q26764819	Saliva as a diagnostic tool for oral and systemic diseases
Q33683154	Salivary biomarkers for detection of oral squamous cell carcinoma - current state and recent advances
Q36270107	Salivary detection of human Papilloma virus 16 & 18 in pre-malignant and malignant lesions of oral cavity: Is it feasible in Pakistani context of Socio-Cultural Taboos?
Q41083203	Salvage surgery for locally recurrent oropharyngeal cancer.
Q35763986	Self-reported oral health, oral hygiene, and oral HPV infection in at-risk women in Ho Chi Minh City, Vietnam
Q60302619	Sensitivity to inhibition of DNA repair by Olaparib in novel oropharyngeal cancer cell lines infected with Human Papillomavirus
Q35034741	Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer
Q41131751	Sexual behaviors and other risk factors for oral human papillomavirus infections in young women
Q39578453	Sexually Transmitted Infections in Youth With Controlled and Uncontrolled Human Immunodeficiency Virus Infection
Q37376441	Significance of microRNA-related variants in susceptibility to recurrence of oropharyngeal cancer patients after definitive radiotherapy
Q36906854	Significant differences in demographic, clinical, and pathological features in relation to smoking and alcohol consumption among 1,633 head and neck cancer patients.
Q52617485	Simultaneous targeting of EGFR, HER2, and HER4 by afatinib overcomes intrinsic and acquired cetuximab resistance in head and neck squamous cell carcinoma cell lines.
Q36177832	Sinonasal inverted papilloma associated with squamous cell carcinoma
Q44529923	Smoking and gender modify the effect of TWIST on patient survival in head and neck squamous carcinoma
Q37416019	Society of behavioral medicine supports increasing HPV vaccination uptake: an urgent opportunity for cancer prevention.
Q37913477	Society, sex, and STIs: human behavior and the evolution of sexually transmitted diseases and their agents
Q37312051	Sonic hedgehog in oral squamous cell carcinoma: An immunohistochemical study
Q38262616	Squamous carcinoma of the ovary.
Q37903899	Squamous cell carcinoma and precursor lesions of the oral cavity: epidemiology and aetiology
Q44177591	Strategies for management of oral cancer in primary and secondary healthcare services
Q41605239	Structural comparison of four different antibodies interacting with human papillomavirus 16 and mechanisms of neutralization
Q49550529	Survival and Functional Outcome after Treatment for Primary Base of Tongue Cancer: A Comparison of Definitive Chemoradiotherapy versus Surgery Followed by Adjuvant Radiotherapy.
Q47716257	Survival and quality of life in oropharyngeal cancer patients treated with primary chemoradiation after salivary gland transfer
Q54341743	Survival in patients with human papillomavirus positive tonsillar cancer in relation to treatment.
Q54380428	Survival of patients with HPV-positive oropharyngeal cancer after radiochemotherapy is significantly enhanced.
Q90230336	Survival outcomes by high-risk human papillomavirus status in nonoropharyngeal head and neck squamous cell carcinomas: A propensity-scored analysis of the National Cancer Data Base
Q89475171	Synergistic effect of cisplatin chemotherapy combined with fractionated radiotherapy regimen in HPV-positive and HPV-negative experimental pharyngeal squamous cell carcinoma
Q97430264	Systematic review and meta-analysis of racial survival disparities among oropharyngeal cancer cases by HPV status
Q35927872	Systemic inflammation is an independent predictive marker of clinical outcomes in mucosal squamous cell carcinoma of the head and neck in oropharyngeal and non-oropharyngeal patients
Q92592749	T-Cell Receptor Gene Therapy for Human Papillomavirus-Associated Epithelial Cancers: A First-in-Human, Phase I/II Study
Q41127889	T-cell immunoglobulin mucin 3 blockade drives an antitumor immune response in head and neck cancer
Q38373043	TEPAPA: a novel in silico feature learning pipeline for mining prognostic and associative factors from text-based electronic medical records
Q38708079	Talking about human papillomavirus and cancer: development of consultation guides through lay and professional stakeholder coproduction using qualitative, quantitative and secondary data
Q36861147	Talking about human papillomavirus and cancer: protocol for a patient-centred study to develop scripted consultations
Q41435861	Tapping the Potential of DNA Delivery with Electroporation for Cancer Immunotherapy
Q26824925	Targeted Therapy in Oropharyngeal Squamous Cell Carcinoma: The Implications of HPV for Therapy
Q38155932	Targeted drugs in combination with radiotherapy for the treatment of solid tumors: current state and future developments
Q37641638	Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer
Q64103655	Temporal Changes in Head and Neck Cancer Incidence in Thailand Suggest Changing Oropharyngeal Epidemiology in the Region
Q34793158	The Composition of Microbiome in Larynx and the Throat Biodiversity between Laryngeal Squamous Cell Carcinoma Patients and Control Population
Q41902984	The Correlation between Chronic Periodontitis and Oral Cancer
Q40246199	The Health System and Policy Implications of Changing Epidemiology for Oral Cavity and Oropharyngeal Cancers in the United States From 1995 to 2016.
Q90197682	The Human Papillomavirus (HPV) E1 protein regulates the expression of cellular genes involved in immune response
Q64927223	The IL-1/IL-1R axis induces greater fibroblast-derived chemokine release in human papillomavirus-negative compared to positive oropharyngeal cancer.
Q57793036	The Impact of Replication Stress in Human Papillomavirus Pathogenesis
Q64979001	The Modifying Effect of a Functional Variant at the miRNA Binding Site in E2F1 Gene on Recurrence of Oropharyngeal Cancer Patients with Definitive Radiotherapy.
Q45355529	The PxDLLCxE sequence in conserved region 2 of human papilloma virus 18 protein E7 is required for E7 binding to centromere protein C.
Q53175931	The Role of miRNAs in Virus-Mediated Oncogenesis.
Q40374172	The biological significance of methylome differences in human papilloma virus associated head and neck cancer
Q37712293	The cancer cell map initiative: defining the hallmark networks of cancer
Q92443921	The changing landscape of head and neck cancer radiotherapy patients: is high-risk, prolonged feeding tube use indicative of on-treatment weight loss?
Q36504144	The chemopreventive and clinically used agent curcumin sensitizes HPV (-) but not HPV (+) HNSCC to ionizing radiation, in vitro and in a mouse orthotopic model.
Q38666893	The cost of oropharyngeal cancer in England: A retrospective hospital data analysis.
Q35094581	The effect of patient characteristics on second primary cancer risk in France
Q34321558	The etiologic role of human papillomavirus in penile cancers: a study in Vietnam
Q38689389	The future of personalised radiotherapy for head and neck cancer
Q36973683	The human papillomavirus type 16 E7 oncoprotein induces a transcriptional repressor complex on the Toll-like receptor 9 promoter
Q35117850	The impact of HPV female immunization in Italy: model based predictions
Q42218799	The impact of HPV infection on survival in a geographically defined cohort of oropharynx squamous cell carcinoma (OPSCC) patients in whom surgical treatment has been one main treatment
Q46641299	The impact of HPV testing for oropharyngeal cancers: Why the addendum matters
Q47435530	The impact of folate intake on the risk of head and neck cancer in the prostate, lung, colorectal, and ovarian cancer screening trial (PLCO) cohort
Q28388257	The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasis
Q33649748	The impact of sphingosine kinase-1 in head and neck cancer
Q54213834	The interplay between alcohol consumption, oral hygiene, ALDH2 and ADH1B in the risk of head and neck cancer.
Q61809644	The molecular biology and HPV drug responsiveness of cynomolgus macaque papillomaviruses support their use in the development of a relevant in vivo model for antiviral drug testing
Q38875247	The molecular mechanism of human papillomavirus-induced carcinogenesis in head and neck squamous cell carcinoma
Q39352364	The national landscape of human papillomavirus-associated oropharynx squamous cell carcinoma
Q35164443	The oral cavity contains abundant known and novel human papillomaviruses from the Betapapillomavirus and Gammapapillomavirus genera
Q30251408	The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer
Q47607159	The prevalence of human papillomavirus in oropharyngeal cancer in a New Zealand population
Q43572474	The psychosocial impact of stigma in people with head and neck or lung cancer.
Q96950525	The radiobiology of HPV-positive and HPV-negative head and neck squamous cell carcinoma
Q89830954	The role of Glial cell derived neurotrophic factor in head and neck cancer
Q24630128	The role of HPV in head and neck cancer and review of the HPV vaccine
Q37668390	The role of Human Papilloma Virus (HPV) vaccination in the prevention of anal cancer in individuals with Human Immunodeficiency Virus-1 (HIV-1) infection
Q37893600	The role of cytopathology in diagnosing HPV induced oropharyngeal lesions.
Q35605731	The role of histologic subtype, p16(INK4a) expression, and presence of human papillomavirus DNA in penile squamous cell carcinoma
Q40952861	The role of human papillomavirus in head and neck squamous cell carcinoma: A case control study on a southern Chinese population
Q38069126	The role of human papillomavirus in nongenital cancers
Q38067674	The role of human papillomavirus in oral squamous cell carcinoma: myth and reality.
Q40081693	The role of human papillomavirus on the prognosis and treatment of oropharyngeal carcinoma
Q35272050	The role of sexual behavior in head and neck cancer: implications for prevention and therapy
Q36765546	The surgical plane for lingual tonsillectomy: an anatomic study
Q34996810	The translational significance of epithelial-mesenchymal transition in head and neck cancer
Q24194851	Therapeutic exercises for affecting post-treatment swallowing in people treated for advanced-stage head and neck cancers
Q38937459	Therapeutic exercises for affecting post-treatment swallowing in people treated for advanced-stage head and neck cancers.
Q42286203	Time trends in the prevalence of HPV in oropharyngeal squamous cell carcinomas in northern Spain (1990-2009).
Q98952641	Time-varying survival effects for squamous cell carcinomas at oropharyngeal and nonoropharyngeal head and neck sites in the United States, 1973-2015
Q39122442	Transcriptionally active human papillomavirus is strongly associated with Barrett's dysplasia and esophageal adenocarcinoma
Q39663809	Transcriptionally-active human papillomavirus is consistently retained in the distant metastases of primary oropharyngeal carcinomas
Q92981780	Transcriptomics and Epigenomics in head and neck cancer: available repositories and molecular signatures
Q38210212	Transoral Robotic Surgery in the HPV Era.
Q34686701	Transoral laser microsurgery for the unknown primary: role for lingual tonsillectomy
Q37700847	Transoral robotic surgery with radial forearm free flap reconstruction: case control analysis
Q44108779	Treatment response in the neck: p16+ versus p16- oropharyngeal cancer
Q57138281	Treatment-naïve HPV+ head and neck cancers display a T-cell-inflamed phenotype distinct from their HPV- counterparts that has implications for immunotherapy
Q33804329	Trends and Patterns of Disparities in Oral Cavity and Pharyngeal Cancer in Serbia: Prevalence and Economic Consequences in a Transitional Country
Q50089949	Trends in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma Incidence, Vermont 1999-2013.
Q35951811	Trends in incidence of oral and pharyngeal carcinoma in Florida: 1981-2008.
Q33617489	Trends in oral cavity, pharyngeal, oesophageal and gastric cancer mortality rates in Spain, 1952-2006: an age-period-cohort analysis
Q34799896	Trends of lip, oral cavity and oropharyngeal cancers in Australia 1982-2008: overall good news but with rising rates in the oropharynx
Q36845824	Trial watch: DNA vaccines for cancer therapy
Q40085419	Tumor DNA: an emerging biomarker in head and neck cancer
Q43291647	Tumor PD-L1 status and CD8+ tumor-infiltrating T cells: markers of improved prognosis in oropharyngeal cancer
Q37586794	Tumor cell anaplasia and multinucleation are predictors of disease recurrence in oropharyngeal squamous cell carcinoma, including among just the human papillomavirus-related cancers
Q61448379	Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy
Q38090596	Tumor-derived exosomes and microvesicles in head and neck cancer: implications for tumor biology and biomarker discovery
Q42241908	Universal vaccination with the quadrivalent HPV vaccine in Austria: impact on virus circulation, public health and cost-effectiveness analysis
Q95282869	Update on oral and oropharyngeal cancer staging - International perspectives
Q47748258	Upregulation of pAKT(Ser473) expression in progression of HPV-positive oropharyngeal squamous cell carcinoma.
Q35594012	Using Texture Analysis to Determine Human Papillomavirus Status of Oropharyngeal Squamous Cell Carcinomas on CT.
Q40639001	Using the Health Belief Model to Examine the Link between HPV Knowledge and Self-Efficacy for Preventive Behaviors of Male Students at a Two-Year College in New York City
Q36747392	Validation of a novel diagnostic standard in HPV-positive oropharyngeal squamous cell carcinoma
Q35916573	Validation that metabolic tumor volume predicts outcome in head-and-neck cancer
Q34555379	Variants in nucleotide excision repair core genes and susceptibility to recurrence of squamous cell carcinoma of the oropharynx
Q64235505	Variations in HPV function are associated with survival in squamous cell carcinoma
Q40701192	Viral infections associated with oral cancers and diseases in the context of HIV: a workshop report
Q36607707	Virology and molecular pathogenesis of HPV (human papillomavirus)-associated oropharyngeal squamous cell carcinoma
Q64076872	Werner Helicase Control of Human Papillomavirus 16 E1-E2 DNA Replication Is Regulated by SIRT1 Deacetylation
Q38859779	Worldwide burden of cancer attributable to HPV by site, country and HPV type.
Q37397524	Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers.
Q85964078	Xerostomia after radiotherapy. What matters--mean total dose or dose to each parotid gland?
Q96166497	ZSCAN4 facilitates chromatin remodeling and promotes the cancer stem cell phenotype
Q84091111	[New aspects of HPV-positive head and neck cancer. Highlights from the 2011 ASCO Congress]
Q54346049	[Update on HPV-induced oropharyngeal cancer].
Q37056861	hpv is here to stay
Q64889726	mTOR Signalling in Head and Neck Cancer: Heads Up.
Q36237523	mTOR as a molecular target in HPV-associated oral and cervical squamous carcinomas
Q57450687	mTOR, metabolism, and the immune response in HPV-positive head and neck squamous cell cancer
Q47391727	p16 Immunohistochemistry in Oropharyngeal Squamous Cell Carcinoma Using the E6H4 Antibody Clone: A Technical Method Study for Optimal Dilution

scholarly article	Q13442814
review article	Q7318358

P356	DOI	10.1016/S1470-2045(10)70017-6
P932	PMC publication ID	5242182
P698	PubMed publication ID	20451455

P50	author	Gypsyamber D'Souza	Q89374611
		William H. Westra	Q98958844
		Arlene A Forastiere	Q100516685
P2093	author name string	Shanthi Marur
P2860	cites work	Basaloid squamous cell carcinoma of the head and neck is a mixed variant that can be further resolved by HPV status	Q81319579
		P16(INK4a) correlates to human papillomavirus presence, response to radiotherapy and clinical outcome in tonsillar carcinoma	Q81586482
		Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review	Q22306450
		Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.	Q27851397
		Global cancer statistics, 2002	Q27860562
		Case-control study of human papillomavirus and oropharyngeal cancer	Q28301695
		Epidemiologic classification of human papillomavirus types associated with cervical cancer	Q29616213
		Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas	Q30783406
		Evidence for a causal association between human papillomavirus and a subset of head and neck cancers	Q33180284
		Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma.	Q33181502
		Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus	Q33197530
		p53: biology and role for cellular radiosensitivity	Q33969887
		Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers	Q34286359
		Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer.	Q34567933
		Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States	Q34743604
		Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial	Q34749494
		Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers	Q34760882
		Oral sexual behaviors associated with prevalent oral human papillomavirus infection	Q34968794
		Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?	Q34971126
		Presence of HPV DNA in convalescent salivary rinses is an adverse prognostic marker in head and neck squamous cell carcinoma	Q35547426
		Does pretreatment seropositivity to human papillomavirus have prognostic significance for head and neck cancers?	Q35647100
		Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment	Q36988805
		Oral human papillomavirus infection before and after treatment for human papillomavirus 16-positive and human papillomavirus 16-negative head and neck squamous cell carcinoma	Q37006630
		Cystic lymph node metastasis in patients with head and neck cancer: An HPV-associated phenomenon	Q37126347
		HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007).	Q37193014
		Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number	Q37342399
		EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer	Q37348956
		Bcl-2 blocks cisplatin-induced apoptosis and predicts poor outcome following chemoradiation treatment in advanced oropharyngeal squamous cell carcinoma	Q37349935
		The biomarkers of human papillomavirus infection in tonsillar squamous cell carcinoma-molecular basis and predicting favorable outcome	Q38428005
		Apoptosis of HeLa cells induced by cisplatin and its mechanism	Q39982262
		The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy	Q41240221
		Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7.	Q41251899
		Lack of association of alcohol and tobacco with HPV16-associated head and neck cancer	Q43428716
		Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma	Q43732858
		Six-month natural history of oral versus cervical human papillomavirus infection	Q43781183
		Human papillomavirus in the oral cavities of children and adolescents	Q43820328
		Human papillomavirus seropositivity and risks of head and neck cancer	Q44212964
		Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck	Q44241369
		Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems	Q44263733
		Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma	Q44681179
		Human papillomavirus frequency in oral and oropharyngeal cancer in Greece.	Q44795916
		Human papillomavirus in oral exfoliated cells and risk of head and neck cancer	Q44802936
		Demographic and risk factors in patients with head and neck tumors.	Q46075627
		Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years	Q46214415
		Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas.	Q46686980
		High association of human papillomavirus infection with oral cancer: a case-control study.	Q46828700
		Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma	Q47741422
		Detection of human papillomavirus-related squamous cell carcinoma cytologically and by in situ hybridization in fine-needle aspiration biopsies of cervical metastasis: a tool for identifying the site of an occult head and neck primary	Q50460659
		Incidence of oral and oropharyngeal cancer in United Kingdom (1990-1999) -- recent trends and regional variation.	Q50776947
		Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection.	Q50857924
		Human papillomavirus and risk of oral cancer.	Q50876407
		Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003.	Q51124767
		Oral and oropharyngeal cancer in The Netherlands between 1989 and 2006: Increasing incidence, but not in young adults.	Q51132386
		Prevalence of human papillomavirus in the oral cavity/oropharynx in a large population of children and adolescents.	Q51740498
		Head and neck squamous cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008, Washington, D.C.	Q51807888
		A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen.	Q51908580
		Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control.	Q52545574
		Human papillomavirus infection and oral cancer: a case-control study in Montreal, Canada.	Q53556529
		Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden.	Q54630232
		Feasibility of quantitative PCR-based saliva rinse screening of HPV for head and neck cancer.	Q54661276
		The incidence of tonsillar cancer in Sweden is increasing	Q58083891
		Oropharyngeal cancer incidence and mortality in Scotland: are rates still increasing?	Q59821789
		Association of papillomavirus with cancers of the head and neck	Q69339660
		Cellular responses of HPV-positive cancer cells to genotoxic anti-cancer agents: repression of E6/E7-oncogene expression and induction of apoptosis	Q71838655
		Head and neck cancer in nonsmokers: a distinct clinical and molecular entity	Q73086603
		[Stage III and IV cancers of the oropharynx: results of a randomized study of Gortec comparing radiotherapy alone with concomitant chemotherapy]	Q73200958
		Human papillomavirus type 16 E6 and HPV-16 E6/E7 sensitize human keratinocytes to apoptosis induced by chemotherapeutic agents: roles of p53 and caspase activation	Q73864322
		Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control	Q74027584
		Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin	Q75207607
		Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck	Q80556204
P433	issue	8
P921	main subject	virus	Q808
		epidemic	Q44512
		head and neck cancer	Q1783924
		head and neck carcinoma	Q18554836
		neck cancer	Q18966654
P304	page(s)	781-789
P577	publication date	2010-05-05
P1433	published in	Lancet Oncology Commission	Q13747613
P1476	title	HPV-associated head and neck cancer: a virus-related cancer epidemic
P478	volume	11

HPV-associated head and neck cancer: a virus-related cancer epidemic

scientific article

Reverse relations